1199 related articles for article (PubMed ID: 15685173)
1. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.
Cai D; Yuan M; Frantz DF; Melendez PA; Hansen L; Lee J; Shoelson SE
Nat Med; 2005 Feb; 11(2):183-90. PubMed ID: 15685173
[TBL] [Abstract][Full Text] [Related]
2. IKK-beta links inflammation to obesity-induced insulin resistance.
Arkan MC; Hevener AL; Greten FR; Maeda S; Li ZW; Long JM; Wynshaw-Boris A; Poli G; Olefsky J; Karin M
Nat Med; 2005 Feb; 11(2):191-8. PubMed ID: 15685170
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance.
Wang XA; Zhang R; She ZG; Zhang XF; Jiang DS; Wang T; Gao L; Deng W; Zhang SM; Zhu LH; Guo S; Chen K; Zhang XD; Liu DP; Li H
Hepatology; 2014 Mar; 59(3):870-85. PubMed ID: 24123166
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance.
Shoelson SE; Lee J; Yuan M
Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S49-52. PubMed ID: 14704745
[TBL] [Abstract][Full Text] [Related]
5. Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro.
Lappas M; Yee K; Permezel M; Rice GE
Endocrinology; 2005 Mar; 146(3):1491-7. PubMed ID: 15564333
[TBL] [Abstract][Full Text] [Related]
6. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.
Remels AH; Gosker HR; Langen RC; Polkey M; Sliwinski P; Galdiz J; van den Borst B; Pansters NA; Schols AM
Biochim Biophys Acta; 2014 Feb; 1842(2):175-85. PubMed ID: 24215713
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
[TBL] [Abstract][Full Text] [Related]
8. Effects of a brief high-fat diet and acute exercise on the mTORC1 and IKK/NF-κB pathways in rat skeletal muscle.
Castorena CM; Arias EB; Sharma N; Cartee GD
Appl Physiol Nutr Metab; 2015 Mar; 40(3):251-62. PubMed ID: 25706655
[TBL] [Abstract][Full Text] [Related]
9. Feed-forward signaling of TNF-alpha and NF-kappaB via IKK-beta pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic mice.
Yang J; Park Y; Zhang H; Xu X; Laine GA; Dellsperger KC; Zhang C
Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1850-8. PubMed ID: 19363130
[TBL] [Abstract][Full Text] [Related]
10. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice.
Cai D; Frantz JD; Tawa NE; Melendez PA; Oh BC; Lidov HG; Hasselgren PO; Frontera WR; Lee J; Glass DJ; Shoelson SE
Cell; 2004 Oct; 119(2):285-98. PubMed ID: 15479644
[TBL] [Abstract][Full Text] [Related]
11. Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-κB and JNK pathways in high-fat-fed OLETF rats.
Yang SJ; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY
J Nutr Biochem; 2015 Mar; 26(3):234-40. PubMed ID: 25488547
[TBL] [Abstract][Full Text] [Related]
12. SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice.
Zadjali F; Santana-Farre R; Vesterlund M; Carow B; Mirecki-Garrido M; Hernandez-Hernandez I; Flodström-Tullberg M; Parini P; Rottenberg M; Norstedt G; Fernandez-Perez L; Flores-Morales A
FASEB J; 2012 Aug; 26(8):3282-91. PubMed ID: 22562833
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of NF-κB p65 (RelA) in Liver Improves Insulin Sensitivity and Inhibits cAMP/PKA Pathway.
Ke B; Zhao Z; Ye X; Gao Z; Manganiello V; Wu B; Ye J
Diabetes; 2015 Oct; 64(10):3355-62. PubMed ID: 26038580
[TBL] [Abstract][Full Text] [Related]
14. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
[TBL] [Abstract][Full Text] [Related]
15. Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance.
Röhl M; Pasparakis M; Baudler S; Baumgartl J; Gautam D; Huth M; De Lorenzi R; Krone W; Rajewsky K; Brüning JC
J Clin Invest; 2004 Feb; 113(3):474-81. PubMed ID: 14755344
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.
Andreakos E; Smith C; Kiriakidis S; Monaco C; de Martin R; Brennan FM; Paleolog E; Feldmann M; Foxwell BM
Arthritis Rheum; 2003 Jul; 48(7):1901-12. PubMed ID: 12847684
[TBL] [Abstract][Full Text] [Related]
17. Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway.
Liu K; Luo T; Zhang Z; Wang T; Kou J; Liu B; Huang F
J Ethnopharmacol; 2011 Jul; 136(3):473-9. PubMed ID: 21296137
[TBL] [Abstract][Full Text] [Related]
18. Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis.
Cavin LG; Venkatraman M; Factor VM; Kaur S; Schroeder I; Mercurio F; Beg AA; Thorgeirsson SS; Arsura M
Cancer Res; 2004 Oct; 64(19):7030-8. PubMed ID: 15466196
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappaB in db/db mice.
Tamura Y; Ogihara T; Uchida T; Ikeda F; Kumashiro N; Nomiyama T; Sato F; Hirose T; Tanaka Y; Mochizuki H; Kawamori R; Watada H
Diabetologia; 2007 Jan; 50(1):131-41. PubMed ID: 17093946
[TBL] [Abstract][Full Text] [Related]
20. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta.
Yuan M; Konstantopoulos N; Lee J; Hansen L; Li ZW; Karin M; Shoelson SE
Science; 2001 Aug; 293(5535):1673-7. PubMed ID: 11533494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
